(Q54081144)

English

Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10462369

Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10462369

1 reference

based on heuristic

inferred from title

author name string

Krowka MJ

1

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10462369

Frantz RP

2

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10462369

McGoon MD

3

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10462369

Severson C

4

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10462369

Plevak DJ

5

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10462369

Wiesner RH

6

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10462369

language of work or name

0 references

publication date

1 September 1999

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10462369

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10462369

30

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10462369

3

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10462369

641-648

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10462369

Primary pulmonary hypertension. A national prospective study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300307

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary vascular disorders in portal hypertension.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300307

7 January 2021

based on heuristic

inferred from DOI database lookup

Distinctive clinical features of portopulmonary hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300307

7 January 2021

based on heuristic

inferred from DOI database lookup

Coexistent pulmonary and portal hypertension: morphologic and clinical features

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300307

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatopulmonary syndrome versus portopulmonary hypertension: distinctions and dilemmas

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300307

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300307

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary hypertension in chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300307

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300307

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300307

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300307

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of the acute hemodynamic effects of prostacyclin and hydralazine in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300307

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300307

7 January 2021

based on heuristic

inferred from DOI database lookup

The acute administration of vasodilators in primary pulmonary hypertension. Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300307

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostacyclin and acetylcholine as screening agents for acute pulmonary vasodilator responsiveness in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300307

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300307

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300307

7 January 2021

based on heuristic

inferred from DOI database lookup

The management of primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300307

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of hemodynamics in pulmonary vascular remodeling: implications for primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300307

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300307

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300307

7 January 2021

based on heuristic

inferred from DOI database lookup

Severe pulmonary hypertension in liver transplant candidates

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300307

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.510300307

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10462369

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10462369

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54081144&oldid=1459702766"